| __timestamp | ACADIA Pharmaceuticals Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 2395000 |
| Thursday, January 1, 2015 | 76369000 | 9057000 |
| Friday, January 1, 2016 | 4406000 | 393000 |
| Sunday, January 1, 2017 | 13060000 | 79309000 |
| Monday, January 1, 2018 | 18330000 | 134428000 |
| Tuesday, January 1, 2019 | 19598000 | 175431000 |
| Wednesday, January 1, 2020 | 20550000 | 124165000 |
| Friday, January 1, 2021 | 19141000 | 121875000 |
| Saturday, January 1, 2022 | 10166000 | 10114000 |
| Sunday, January 1, 2023 | 45731000 | 9206000 |
Cracking the code
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. This chart offers a fascinating glimpse into the cost of revenue trends for ACADIA Pharmaceuticals Inc. and Wave Life Sciences Ltd. over the past decade.
ACADIA Pharmaceuticals Inc. has shown a fluctuating cost of revenue, peaking in 2015 with a 76% increase from the previous year. However, by 2022, costs had decreased by 85% from their 2015 high, indicating a strategic shift or operational efficiency.
Conversely, Wave Life Sciences Ltd. experienced a dramatic rise in costs, with a staggering 7,200% increase from 2014 to 2019. This surge reflects the company's aggressive expansion and investment in research and development.
These contrasting trends highlight the diverse strategies employed by biotech firms in managing their financial health.
Analyzing Cost of Revenue: Johnson & Johnson and Wave Life Sciences Ltd.
Takeda Pharmaceutical Company Limited vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc.
Analyzing Cost of Revenue: United Therapeutics Corporation and Wave Life Sciences Ltd.
Cost Insights: Breaking Down Catalent, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Cost Insights: Breaking Down ADMA Biologics, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Perrigo Company plc vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Mesoblast Limited
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Xencor, Inc.
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd.
Cost of Revenue Comparison: Wave Life Sciences Ltd. vs MiMedx Group, Inc.